Journal of Geriatric Cardiology最新文献

{"title":"Exercise-based real-time telerehabilitation for older patients recently discharged after transcatheter aortic valve implantation: An extended feasibility study.","authors":"Barbara Cristina Brocki, Jan Jesper Andreasen, Jens Aarøe, Jane Andreasen, Charlotte B Thorup","doi":"10.26599/1671-5411.2023.11.003","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.11.003","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the extended feasibility of a telerehabilitation program and its effects on physical performance in older adults who have recently undergone transcatheter aortic valve implantation (TAVI).</p><p><strong>Methods: </strong>In this single-center feasibility study, patients underwent an eight-week telerehabilitation program, involving web-based home exercise training twice weekly, an activity tracker, access to an informative website, and one online session with a nurse, starting one-week postoperative. Data collection was performed before surgery and three months postoperative. The feasibility of the intervention was based on recruitment and adherence to the program. As a secondary outcome, we evaluated the change in six-minute walk distance from before surgery to three months postoperative.</p><p><strong>Results: </strong>Forty-one patients scheduled for TAVI were assessed for eligibility; 15 patients (37%) were enrolled. Of these, eight were excluded after surgery due to tiredness (<i>n</i> = 2), non-cardiac related hospital readmission (<i>n</i> = 2), fluctuating health (<i>n</i> = 1), death during hospital stay (<i>n</i> = 1), and reduced cognition (<i>n</i> = 2). Seven patients completed the eight-week web-based intervention and were evaluated three months postoperative. Their median (IQR) age was 83 [81, 87] years, and the sample comprised three men and four women. Their walked distance improved from median (IQR) 262 [199, 463] before surgery, to 381 [267, 521] meters three months postoperative. No adverse events were reported.</p><p><strong>Conclusion: </strong>Web-based telerehabilitation, including supervised exercise training, in older adults who have recently undergone TAVI was feasible for a small number of patients who completed the eight-week intervention. This was reflected in an improvement in their walked distance three months after the surgery. However, the low recruitment and retention rates do question the overall feasibility of this intervention in a frail, older population of post-TAVI patients.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 11","pages":"767-778"},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10716611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lipopolysaccharides protect mesenchymal stem cell against cardiac ischemia-reperfusion injury by HMGB1/STAT3 signaling.","authors":"Jing-Yi Wen, Hui-Xi Peng, Dan Wang, Zhi-Min Wen, Yu-Tong Liu, Jian Qu, Hong-Xuan Cui, Yu-Ying Wang, Yan-Lin DU, Ting Wang, Cong Geng, Bing Xu","doi":"10.26599/1671-5411.2023.11.007","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.11.007","url":null,"abstract":"<p><strong>Background: </strong>Myocardial ischemia-reperfusion (I/R) is a serious and irreversible injury. Bone marrow-derived mesenchymal stem cells (MSCs) is considered to be a potential therapy for I/R injury due to the paracrine effects. High-mobility group box 1 (HMGB1) is a novel mediator in MSC and regulates the response of inflammation injury. Signal Transduction and Transcription Activator 3 (STAT3) is a critical transcription factor and important for release of paracrine factors. However, the relationship between HMGB1 and STAT3 in paracrine effect of MSC remains unknown.</p><p><strong>Methods: </strong><i>In vitro</i>, hypoxia/reoxygenation injury model was established by AnaeroPack System and examined by Annexin V flow cytometry, CCK8 assay and morphology observation. Detection of apoptotic proteins and protein expression of HMGB1 and STAT3 by Western blot.</p><p><strong>Results: </strong>The conditioned medium of MSCs with or without LPS pretreatment was cocultured with H9C2 cells for 24 h before hypoxia treatment and MSC showed obvious cardiomyocytes protect role, as evidence by decreased apoptosis rate and improved cells viability, and LPS pretreated MSC exhibited better protect role than untreated MSC. However, such effect was abolished in HMGB1 deficiency group, silencing HMGB1 decreased the secretion of vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), insulin growth factor (IGF), cell viability, and the expression of STAT3. Furthermore, STAT3 silence attenuated the protective effect of LPS in MSC.</p><p><strong>Conclusions: </strong>These findings suggested that LPS improved MSC-mediated cardiomyocytes protection by HMGB1/STAT3 signaling.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 11","pages":"801-812"},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10716610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Circulating circRNA expression profile and its potential role in late recurrence of paroxysmal atrial fibrillation post catheter ablation.","authors":"Shan-Shan Liu, Hong-Yang Guo, Jian Zhu, Jin-Ling Ma, Sai-Zhe Liu, Kun-Lun He, Su-Yan Bian","doi":"10.26599/1671-5411.2023.11.006","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.11.006","url":null,"abstract":"<p><strong>Background: </strong>Catheter-based pulmonary vein isolation (PVI) is an effective and well-established intervention for symptomatic paroxysmal atrial fibrillation (PAF). Nevertheless, late recurrences of atrial fibrillation (LRAF) occurring during 3 to 12 months are common, and the underlying mechanisms remain elusive. Circular RNAs (circRNAs) in atrial tissue have been linked to the pathophysiological mechanisms and progression of PAF in a few studies. However, their expression patterns in peripheral blood and regulatory function in LRAF are not clear.</p><p><strong>Methods: </strong>In the present study, the expression profile of circulating circRNAs in three paired nonvalvular PAF patients with or without LRAF was investigated by high-throughput sequencing and validated by quantitative real-time polymerase chain reaction (qRT-PCR). Bioinformatics analyses, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and circRNA/miRNA regulatory network, were performed to predict the functions and potential regulatory roles of differentially expressed (DE) circRNAs.</p><p><strong>Results: </strong>A total of 12,834 circRNAs, comprising 5,491 down-regulated and 7,343 up-regulated circRNAs, were found to be DE in blood smaples from the two groups in peripheral blood between LRAF and non-recurrence control individuals. The most enriched GO categories in terms of molecular function, biological process, and cellular component features were catalytic activity, cellular metabolic process, and intracellular part, respectively. The KEGG enrichment study revealed that the most important metabolic process controlled by DE circRNAs is endocytosis. In the circRNA/microRNAs interaction network, four up-regulated circRNAs (hsa_circ_0002665, hsa_circ_0001953, hsa_circ_0003831, and hsa_circ_0040533) and one down-regulated circRNA (hsa_circ_0041103) were predicted to play potential regulatory roles in the pathogenesis of LRAF.</p><p><strong>Conclusions: </strong>This investigation discovered the expression pattern of circulating circRNAs that is indicative of PAF late recurrence, which may serve as risk markers or therapeutic targets for LRAF after PVI.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 11","pages":"788-800"},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10716615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug-coated balloons for the treatment of ostial left anterior descending or ostial left circumflex artery lesions: a patient-level propensity score-matched analysis.","authors":"Liang Pan, Wen-Jie Lu, Zhan-Ying Han, San-Cong Pan, Xi Wang, Ying-Guang Shan, Meng Peng, Xiao-Fei Qin, Guo-Ju Sun, Pei-Sheng Zhang, Jian-Zeng Dong, Chun-Guang Qiu","doi":"10.26599/1671-5411.2023.10.005","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.10.005","url":null,"abstract":"<p><strong>Background: </strong>Controversy exists as to the optimal treatment approach for ostial left anterior descending (LAD) or ostial left circumflex artery (LCx) lesions. Drug-coated balloons (DCB) may overcome some of the limitations of drug-eluting stents (DES). Therefore, we investigated the security and feasibility of the DCB policy in patients with ostial LAD or ostial LCx lesions, and compared it with the conventional DES-only strategy.</p><p><strong>Methods: </strong>We retrospectively enrolled patients with <i>de novo</i> ostial lesions in the LAD or LCx who underwent interventional treatment. They were categorized into two groups based on their treatment approach: the DCB group and the DES group. The treatment strategies in the DCB group involved the use of either DCB-only or hybrid strategies, whereas the DES group utilized crossover or precise stenting techniques. Two-year target lesion revascularization was the primary endpoint, while the rates of major adverse cardiovascular events, cardiac death, target vessel myocardial infarction, and vessel thrombosis were the secondary endpoints. Using propensity score matching, we assembled a cohort with comparable baseline characteristics. To ensure result analysis reliability, we conducted sensitivity analyses, including interaction, and stratified analyses.</p><p><strong>Results: </strong>Among the 397 eligible patients, 6.25% of patients who were planned to undergo DCB underwent DES. A total of 108 patients in each group had comparable propensity scores and were included in the analysis. Two-year target lesion revascularization occurred in 5 patients (4.90%) and 16 patients (16.33%) in the DCB group and the DES group, respectively (odds ratio = 0.264, 95% CI: 0.093-0.752, <i>P</i> = 0.008). Compared with the DES group, the DCB group demonstrated a lower major adverse cardiovascular events rate (7.84% <i>vs.</i> 19.39%, <i>P</i> = 0.017). However, differences with regard to cardiac death, non-periprocedural target vessel myocardial infarction, and definite or probable vessel thrombosis between the groups were non-significant.</p><p><strong>Conclusions: </strong>The utilization of the DCB approach signifies an innovative and discretionary strategy for managing isolated ostial lesions in the LAD or LCx. Nevertheless, a future randomized trial investigating the feasibility and safety of DCB compared to the DES-only strategy specifically for <i>de novo</i> ostial lesions in the LAD or LCx is highly warranted.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"716-727"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients.","authors":"Han-Yang Liang, Dong Liu, Hao Wang, Zheng-Qing Ba, Ying Xiao, Yi-Lu Liu, Yong Wang, Jian-Song Yuan","doi":"10.26599/1671-5411.2023.10.002","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.10.002","url":null,"abstract":"<p><strong>Background: </strong>Both lung cancer and cardiometabolic diseases are leading causes of death in China, and they share some common risk factors. However, the prevalence and long-term effect of pre-existing cardiometabolic comorbidities (CMCs) on the survival of middle-aged and elderly lung cancer patients are still not clear.</p><p><strong>Methods: </strong>We consecutively recruited 3477 non-small cell lung cancer (NSCLC) patients between January 2011 and December 2018 from four cancer specialty hospitals in China. Univariable and multivariable adjusted Cox proportional hazard models were conducted to evaluate the risk factors associated with mortality. Hazard ratio (HR) for mortality and corresponding 95% CI were calculated.</p><p><strong>Results: </strong>The prevalence of CMCs was 30.0% in middle-aged NSCLC patients and 45.5% in elderly NSCLC patients. Log-rank analysis presented statistically significant differences in median survival time between patients with CMCs and without CMCs in both the middle-aged group (21.0 months <i>vs.</i> 32.0 months, <i>P</i> < 0.01) and the elderly group (13.0 months <i>vs.</i> 17.0 months, <i>P</i> = 0.01). Heart failure (HR = 1.754, 95% CI: 1.436-2.144, <i>P</i> < 0.001) and venous thrombus embolism (HR = 2.196, 95% CI: 1.691-2.853, <i>P</i> < 0.001) were independent risk factors for the survival of middle-aged NSCLC patients, while heart failure (HR = 1.709, 95% CI: 1.371-2.130, <i>P</i> < 0.001) continued to decrease overall survival in the elderly group. Hyperlipidemia may be a protective factor for survival in middle-aged group (HR = 0.741, 95% CI: 0.566-0.971, <i>P</i> = 0.030).</p><p><strong>Conclusions: </strong>Our findings demonstrate for the first time the prevalence and prognostic value of pre-existing CMCs in Chinese middle-aged and elderly NSCLC patients.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"737-747"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630173/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history: a prospective propensity score-matched cohort study.","authors":"Wen-Li Dai, Zi-Xu Zhao, Chao Jiang, Liu He, Ke-Xin Yao, Yu-Feng Wang, Ming-Yang Gao, Yi-Wei Lai, Jing-Rui Zhang, Ming-Xiao Li, Song Zuo, Xue-Yuan Guo, Ri-Bo Tang, Song-Nan Li, Chen-Xi Jiang, Nian Liu, De-Yong Long, Xin DU, Cai-Hua Sang, Jian-Zeng Dong, Chang-Sheng Ma","doi":"10.26599/1671-5411.2023.10.001","DOIUrl":"10.26599/1671-5411.2023.10.001","url":null,"abstract":"<p><strong>Background: </strong>Patients with atrial fibrillation (AF) and prior stroke history have a high risk of cardiovascular events despite anticoagulation therapy. It is unclear whether catheter ablation (CA) has further benefits in these patients.</p><p><strong>Methods: </strong>AF patients with a previous history of stroke or systemic embolism (SE) from the prospective Chinese Atrial Fibrillation Registry study between August 2011 and December 2020 were included in the analysis. Patients were matched in a 1:1 ratio to CA or medical treatment (MT) based on propensity score. The primary outcome was a composite of all-cause death or ischemic stroke (IS)/SE.</p><p><strong>Results: </strong>During a total of 4.1 ± 2.3 years of follow-up, the primary outcome occurred in 111 patients in the CA group (3.3 per 100 person-years) and in 229 patients in the MT group (5.7 per 100 person-years). The CA group had a lower risk of the primary outcome compared to the MT group [hazard ratio (HR) = 0.59, 95% CI: 0.47-0.74, <i>P</i> < 0.001]. There was a significant decreasing risk of all-cause mortality (HR = 0.43, 95% CI: 0.31-0.61, <i>P</i> < 0.001), IS/SE (HR = 0.73, 95% CI: 0.54-0.97, <i>P</i> = 0.033), cardiovascular mortality (HR = 0.32, 95% CI: 0.19-0.54, <i>P</i> < 0.001) and AF recurrence (HR = 0.33, 95% CI: 0.30-0.37, <i>P</i> < 0.001) in the CA group compared to that in the MT group. Sensitivity analysis generated consistent results when adjusting for time-dependent usage of anticoagulants.</p><p><strong>Conclusions: </strong>In AF patients with a prior stroke history, CA was associated with a lower combined risk of all-cause death or IS/SE. Further clinical trials are warranted to confirm the benefits of CA in these patients.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"707-715"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of complete revascularization in acute coronary syndrome after 75 years old: insights from the BleeMACS registry.","authors":"Ge Wang, Xiu-Huan Chen, Si-Yi Li, Ze-Kun Zhang, Wei Gong, Yan Yan, Shao-Ping Nie, José P Henriques","doi":"10.26599/1671-5411.2023.10.003","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.10.003","url":null,"abstract":"<p><strong>Background: </strong>The prognostic benefit of complete revascularization in elderly patients (aged over 75 years) with multi-vessel disease and acute coronary syndrome (ACS) is currently unclear. This study aimed to determine the long-term prognostic impact of complete revascularization in this population.</p><p><strong>Methods: </strong>We conducted this study using data obtained from the BleeMACS (Bleeding complications in a Multicenter registry of patients discharged after an Acute Coronary Syndrome) registry, which was carried out from 2003 to 2014. The objective was to categorize older patients diagnosed with ACS into two groups: those who underwent complete revascularization and those who did not. Propensity score matching and the Kaplan-Meier analysis were employed to examine differences in one-year clinical outcomes. The primary endpoint was major adverse cardiovascular event (MACE), which encompassed a combination of all-cause mortality and myocardial infarction.</p><p><strong>Results: </strong>Out of 1263 patients evaluated, 445 patients (35.2%) received complete revascularization. Patients who underwent complete revascularization had a higher prevalence of hypertension and prior percutaneous coronary intervention compared to those who did not. During the one-year follow-up period, complete revascularization was associated with a significantly decreased risk of MACE [13.7% <i>vs.</i> 20.5%, hazard ratio (HR) = 0.63, 95% CI: 0.45-0.88, <i>P</i> = 0.007] and a lower risk of myocardial infarction (5.9% <i>vs.</i> 9.9%, HR = 0.55, 95% CI: 0.33-0.92, <i>P</i> = 0.02). However, it was not linked to a lower risk of all-cause death (9.5% <i>vs.</i> 13.5%, HR = 0.68, 95% CI: 0.45-1.02, <i>P</i> = 0.06). Similar results were observed in the subgroup analysis.</p><p><strong>Conclusions: </strong>Long-term clinical improvements were observed in ACS patients aged over 75 years with multi-vessel disease who achieved complete revascularization. Therefore, adhering to guidelines for complete revascularization should be recommended for elderly patients.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"728-736"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Masquerading bundle branch block with intermittent right ventricular pacing in a patient with acute coronary syndrome.","authors":"Vsevolod Tabachnikov, Yuval Avidan","doi":"10.26599/1671-5411.2023.10.007","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.10.007","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"762-766"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630170/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A simultaneous occurrence of pulmonary embolism and cerebral infarction following Micra™ leadless pacemaker implantation.","authors":"Song-Hua Li, Shao-Hua Dong, Tong Kan, Sun Yue, Bo Li, Yang Lu, Pan Li, Zhi-Fu Guo","doi":"10.26599/1671-5411.2023.10.006","DOIUrl":"https://doi.org/10.26599/1671-5411.2023.10.006","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"756-759"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiovascular outcomes and mortality after abnormal myocardial perfusion scans in the elderly: a retrospective study at a tertiary care institution.","authors":"Shishir Gupta, Sohum Sheth, Sujay Kamisetty, Marco Foreman, David Winchester","doi":"10.26599/1671-5411.2023.10.008","DOIUrl":"10.26599/1671-5411.2023.10.008","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"20 10","pages":"760-761"},"PeriodicalIF":2.5,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}